SANA — Sana Biotechnology Share News
0.000.00%
Last trade - 00:00- $709.48m
- $548.99m
Brief: Sana Biotechnology Inc - QTRLY Loss Per Share $0.39
Sana Biotechnology Inc expected to post a loss of 51 cents a share - Earnings Preview
Brief: Sana Biotechnology Presents Data At ISSCR 2022 Annual Meeting Showing Survival Of Transplanted Hypoimmune Ipsc-Derived Differentiated Cell Types Without Immunosuppression In Non-Human Primates
Brief: Sana Biotechnology Announces Plan To Relocate Manufacturing To Bothell, Washington Along With Key Executive Hires In Manufacturing And Regulatory
Sana Biotechnology Inc reports results for the quarter ended in March - Earnings Summary
Sana Biotechnology Inc expected to post a loss of 47 cents a share - Earnings Preview
Sana Biotechnology Inc expected to post a loss of 47 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Digitalbridge Group, Joann, Park Ohio Holdings
Brief: Sana Biotechnology Reports Q4 And Full Year 2021 Financial Results
Brief: Sana Biotechnology Obtains Exclusive License From National Institutes Of Health For CD22 Car Construct
Brief: Sana Biotechnology, Iaso Biotherapeutics And Innovent Biologics In Non-Exclusive License Agreement For BCMA CAR Construct
Brief: Sana Biotechnology Reports Q3 2021 Financial Results
Brief: Sana Biotechnology Obtains A Non-Exclusive License To CRISPR Cas12b Gene Editing Technology
Sana Biotechnology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Sana Biotechnology Reports Q2 2021 Financial Results
Brief: Sana Biotechnology Reports Q1 2021 Financial Results
Brief: Sana Biotechnology Reports Fourth Quarter And 2020 Financial Results And Business Updates
Sana Biotech valued at over $6 bln in market debut
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM